Delivery Order SPE2DB22D1002-SPE2DB25FLEF8
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $1,040.85 and a period of performance through May 19, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The contract is not set aside and has a firm fixed price of $10,437.90, with a completion date of June 10, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $2,408.46 and a period of performance through May 9, 2025. The contract is a Firm Fixed Price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $1,030.56 and a period of performance ending on May 28, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $1,559.46 and a period of performance through July 16, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a medical product, with a ceiling value of $1,472.61. The contract is a firm fixed price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply ENGERIX-B 20 MCG/ML SYRNML medical supplies. The $2,102.28 firm fixed price contract has a completion date of July 2, 2025 and is not designated as a set-aside. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a global pharmaceutical support vehicle...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,052.41 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The contract has a completion date of February 9, 2024 and was awarded on February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a vaccine product. The contract has a ceiling value of $1,256.33 and an ultimate completion date of June 23, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is the prime contractor...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $1,273.12. The contract is a Firm Fixed Price (FFP) arrangement with a final completion date of May 13, 2025. The contract is not set aside for any specific business classification. Amerisourcebergen Drug...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLEF8Delivery Order
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $1,944.61 and a period of performance through July 1, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the Defense Health Agency, U.S. Coast Guard, and other government customers. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 6/30/25 |